Reckitt Benckiser Group plc

As of December 31, 2025, Reckitt Benckiser Group plc carries a market capitalization of 46.14B, placing it among publicly traded companies globally. Its enterprise value stands at 53.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Reckitt Benckiser Group plc's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2025, Reckitt Benckiser Group plc has 645.49M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Reckitt Benckiser Group plc maintains a current ratio of 0.85, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Reckitt Benckiser Group plc's stock has declined approximately 6.18% over the past 52 weeks. The 50-day moving average sits at 59.94, while the 200-day moving average is 61.16.

As of December 31, 2025, Reckitt Benckiser Group plc holds 2.03B in cash and equivalents against 9.67B in total debt, resulting in a net debt position of 7.32B. Total book value stands at 8.88B, with working capital of -1.16B providing operational flexibility.

Reckitt Benckiser Group plc's most recent stock split took place on February 2, 2026 with a 25:24 split ratio.